Zanubrutinib
Class
Targeted therapy
Subclass
Bruton tyrosine kinase inhibitors
Substance name
Zanubrutinib
Brand names
Brukinsa®
Common formulations
Gelatin-coated capsule
Dosage and administration
Adults patients
Chronic lymphocytic leukemia
Follicular lymphoma • Relapsed or refractory, received ≥ 2 prior lines of systemic therapy
Mantle cell lymphoma • Received at least one prior therapy
Marginal zone lymphoma • Relapsed or refractory, received at least one anti-CD20-based regimen
Small lymphocytic lymphoma
Waldenstrom's macroglobulinemia
Indications for use
Labeled indications
Adults
Interactions
Drug(s)
Check Interactions
Reset
What did you think about this content?
Sign up for free to access the full drug resource